tremelimumab,durvalumab,zolbetuximab,regorafenib,Epirubicin,Cisplatin,Capecitabine,Paclitaxel,Carboplatin,Docetaxel,oxaliplatin,Leucovorin,5-Fluorouracil
astellas,astrazeneca,bayer
[]
day 1 #gi23 highlights #communityoncology 1. #neoagis: chemo vs cross 2. #infinity: neoadj io dmmr g/gej ca 3. #spotlight: cldn18.2 (importance of ngs)- new soc 4. #integrateiia: rego in pretreated pts #onced #meded #oncology #gism
Practice changing #Oncology news from #CommunityOncologists perspective w/ Rohit Gosain @UPMCHillmanCC & Rahul Gosain @WilmotCancer. Views are our own.